Cargando…
What have we learned from observational studies and clinical trials of mild to moderate COPD?
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. It is well established that patients with mild to moderate disease represent the majority of patients with COPD, and patients with mild COPD already have measurable physiological impairment with incre...
Autores principales: | Barrecheguren, Miriam, González, Cruz, Miravitlles, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142698/ https://www.ncbi.nlm.nih.gov/pubmed/30223834 http://dx.doi.org/10.1186/s12931-018-0882-0 |
Ejemplares similares
-
COPD heterogeneity: implications for management
por: Barrecheguren, Miriam, et al.
Publicado: (2016) -
Is a previous diagnosis of asthma a reliable criterion for asthma–COPD overlap syndrome in a patient with COPD?
por: Barrecheguren, Miriam, et al.
Publicado: (2015) -
Population-based study of LAMA monotherapy effectiveness compared with LABA/LAMA as initial treatment for COPD in primary care
por: Barrecheguren, Miriam, et al.
Publicado: (2018) -
Evaluating the impact of morning symptoms in COPD using the Capacity of Daily Living during the Morning (CDLM) questionnaire
por: Núñez, Alexa, et al.
Publicado: (2018) -
Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD
por: Monteagudo, Mònica, et al.
Publicado: (2021)